Efectividad y satisfacción del tratamiento de la dislipidemia con pitavastatinastudio observacional, postautorización, descriptivo y multicéntrico (estudio REINA)

With the practice-shifting changes made with the most recent guidelines for treating blood cholesterol, more older patients may be prescribed statin therapy. Therefore, it is imperative that practitioners have not only a working knowledge of information related to statins, but more specifically to their efficacy and safety in elderly populations. Pitavastatin is the most recent statin to receive regulatory approval. It is indicated for the treatment of primary hyperlipidemia or mixed dyslipidemia as an adjunctive therapy to diet. The overall body of evidence for the efficacy and safety of pitavastatin in elderly patients is small. The available data suggest that the ability of pitavastatin to lower low-density lipoprotein cholesterol in elderly patients is at least similar, and may be greater than that seen in comparatively younger cohorts. Taken together, the limited available data suggest that pitavastatin is effective at improving lipid parameters in elderly patients with a similar safety profile to other agents in the class. Until data become available distinguishing pitavastatin from the other available options, its ultimate role in the hyperlipidemia treatment armamentarium remains unclear.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Efectividad y satisfacción del tratamiento de la dislipidemia con pitavastatinastudio observacional, postautorización, descriptivo y multicéntrico (estudio REINA)

Cited by 2 publications

References 37 publications

Importancia de la dislipidemia en la enfermedad cardiovascular: un punto de vista

Importancia de la dislipidemia en la enfermedad cardiovascular: un punto de vista

Benefit–risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients

Contact Info

Product

Resources

About

Efectividad y satisfacción del tratamiento de la dislipidemia con pitavastatinastudio observacional, postautorización, descriptivo y multicéntrico (estudio REINA)

Cited by 2 publications

References 37 publications

Importancia de la dislipidemia en la enfermedad cardiovascular: un punto de vista

Importancia de la dislipidemia en la enfermedad cardiovascular: un punto de vista

Benefit&ndash;risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients

Contact Info

Product

Resources

About

Benefit–risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients